New hydrophobicity constants of substituents in pyrazine rings derived from RP-HPLC study

Collection of Czechoslovak Chemical Communications

Volumn 73, Issue 1, 2008, Pages 1-18

  Kučerová Chlupáčová, Marta ^a   Opletalová, Veronika ^a   Jampílek, Josef ^b   Doležel, Jan ^a   Dohnal, Jiří ^b   Pour, Milan ^a   Kuneš, Jiří ^a   Voříšek, Viktor ^c  

^a Charles University in Prague Faculty of Pharmacy   (Czech Republic)

^b Zentiva Prague   (Czech Republic)

^c UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

Author keywords

Acetylpyrazine; Chromatography; Homolytic acetylation; Homolytic alkylation; Hydrophobicity; Lipophilicity; Pyrazinecarbonitrile; Pyrazines

Indexed keywords

EID: 42049087409     PISSN: 00100765     EISSN: None     Source Type: Journal    
DOI: 10.1135/cccc20080001     Document Type: Article

References (85)

1. a) Lüllmann H., Mohr K., Wehling M.: Farmakologie a toxikologie. Grada Publishing, Praha 2002;
2. b) Doležal M.: Praktické léká renství 2005, 1, 16.
3. Tripathi R. P., Tewari N., Dwivedi N., Tiwari V. K.: Med. Res. Rev. 2005, 25, 93.
4. a) Bergmann K. E., Cynamon M. H., Welch J. T.: J. Med. Chem. 1996, 39, 3394;
5. b) Jampílek J., Doležal M., Buchta V.: Med. Chem. 2007, 3, 277.
6. Hirsh A. J., Molino B. F., Zhang J., Astakhova N., Geiss W. B., Sargent B. J., Swenson B. D., Usyatinsky A., Wyle M. J., Boucher R. C., Smith R. T., Zamurs A., Johnson M. R.: J. Med. Chem. 2006, 49, 4098.
7. a) Kok P., Buijs M. M., Kok S. W., van Ierssel I. H. A. P., Frölich M., Roelfsema F., Voshol P. J., Meinders A. E., Pijl H.: Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 286, R698;
8. b) Jensen M. D.: Obesity 2006, 14, 143S.
9. Doležal M., Jampílek J., Osička Z., Kuneš J., Buchta V., Víchová P.: Farmaco 2003, 58, 1105.
10. Doležal M., Hartl J., Miletín M., Macháček M., Král'ová K.: Chem. Pap. 1999, 53, 126.
11. Zimčík P., Miletín M., Musil Z., Kopecký K., Kubza L., Brault D.: J. Photochem. Photobiol., A 2006, 183, 59.
12. a) Bonnet P. A., Michel A., Laurent F., Sablayrolles C., Rechencq E., Mani J. C., Boucard M., Chapat J. P.: J. Med. Chem. 1992, 35, 3353;
13. b) El-Emary T. I., El-Dean K., El-Kashef H. S.: Farmaco 1998, 53, 383;
14. c) Creighton C. J., Zapf C. W., Bu J. H., Goodman M.: Org. Lett. 1999, 1, 1407;
15. d) Blanchard S., Rodriguez I., Kuehm-Caubère C., Renard P., Pfeiffer B., Guillaumet G., Caubère P.: Tetrahedron 2002, 58, 3513;
16. e) Jacquot D. E. N., Lindel T.: Chem. Eur. J. 2004, 10, 1141;
17. f) El-Hawash S. A. M., Habib N. S., Kassem M. A.: Arch. Pharm. Chem. Life Sci. 2006, 339, 564.
18. a) Anonymous: Drugs Future 1999, 24, 1140;
19. b) Tsai T.-H., Liang C.-C.: Int. J. Pharm. 2001, 216, 61;
20. c) Qi X., Ackermann C., Sun D., Sheng M., Hou H.: Int. J. Pharm. 2003, 253, 177.
21. a) Cheeseman G. W. H., Werstiuk E. S. G. in: Advances in Heterocyclic Chemistry (A. R. Katritzky and A. J. Boulton, Eds), Vol. 14, pp. 99-209. Academic Press, New York, London 1972;
22. b) Sato N., Kadota H.: J. Heterocycl. Chem. 1992, 29, 1685;
23. c) Albaneze-Walker J., Zhao M., Baker M. D., Dormer P. G., McNamara J.: Tetrahedron Lett. 2002, 43, 6747.
24. a) Kerler J., van der Ven J. G. M., Weenen H.: Food Rev. Int. 1997, 13, 553;
25. b) Pustějovská M., Maděra J., Červený L.: Chem. Listy 1998, 92, 402;
26. c) Opletalovâ V., Domonhedo C.: Chem. Listy 1999, 93, 15.
27. a) Dlabal K., Palát K., Lyčka A., Odlerová Z.: Collect. Czech. Chem. Commun. 1990, 55, 2493;
28. b) Doležal M., Hartl J., Lyčka A., Buchta V., Odlerová Z.: Collect. Czech. Chem. Commun. 1995, 60, 1236;
29. c) Opletalová V., Hartl J., Patel A., Boulton M.: Collect. Czech. Chem. Commun. 1995, 60, 1551;
30. d) Opletalová V., Patel A., Boulton M., Dundrová A., Lacinová E., Převorová M., Appeltauerová M., Coufalová M.: Collect. Czech. Chem. Commun. 1996, 61, 1093;
31. e) Doležal M., Hartl J., Lyčka A., Buchta V., Odlerová Z.: Collect. Czech. Chem. Commun. 1996, 61, 1102;
32. f) Hartl J., Doležal M., Krinková J., Lyčka A., Odlerová Z.: Collect. Czech. Chem. Commun. 1996, 61, 1109;
33. g) Opletalová V., Hartl J., Domonhedo C., Patel A.: Folia Pharm. Univ. Carol. 1999, 24, 29;
34. h) Švandová M.: M.S. Thesis. Charles University, Prague 2001;
35. i) Posledníková M.: M.S. Thesis. Charles University, Prague 2002;
36. j) Zobalová D.: M.S. Thesis. Charles University, Prague 2003;
37. k) Opletalová V., Chlupáčová M., Posledníková M., Zobalová D., Kuneš J., Voříšek V.: Proceedings of the 56th Meeting of Chemical Societies, Ostrava, Czech Republic, September 6-9, 2004; in: Chem. Listy 2004, 98, 669.
38. Opletalová V., Hartl J., Lyčka A.: Proceedings of Symposium on Heterocyclic Compounds, Hradec Králové, Czech Republic, June 28-July 1, 1995; in: Folia Pharm. Univ. Carol. 1995, 18 (Suppl.), 171.
39. a) Opletalová V., Hartl J., Patel A., Palát K., Buchta V.: Farmaco 2002, 57, 135;
40. b) Opletalová V., Chlupáčová M., Posledníková M., Kuneš J., Silva L., Buchta V., Jun D.: Proceedings of Joint Meeting of the Czech Pharmaceutical Society, German Pharmaceutical Society and Austrian Pharmaceutical Society, Regensburg, Germany, October 6-9, 2004, p. 121. German Pharmaceutical Society, Frankfurt/Main 2004;
41. c) Chlupáčová M., Opletalová V., Doseděl M., Švédová L., Silva L., Buchta V.: Proceedings of the 34th Conference "Synthesis and Analysis of Drugs", Brno, Czech Republic, September 12-14, 2005, p. 66. Veterinary and Pharmaceutical University, Brno 2005;
42. d) Opletalová V., Pour M., Buchta V., Silva L., Král'ová K., Chlupáčová M., Meltrová D., Peterka M., Posledníková M.: Collect. Czech. Chem. Commun. 2006, 71, 44.
43. Chlupáčová M., Opletalová V., Silva L., Buchta V., Kuneš J.: Proceedings of Joint Meeting of the Czech Pharmaceutical Society, German Pharmaceutical Society and Austrian Pharmaceutical Society, Regensburg, Germany, October 6-9, 2004, p. 100. German Pharmaceutical Society, Frankfurt/Main 2006.
44. a) Opletalová V., Pour M., Kuneš J., Silva L., Buchta V., Jampílek J., Richardson D. R., Kalinowski D., Švandová M., Zobalová D.: Proceedings of the 11th Blue Danube Symposium on Heterocyclic Chemistry, Brno, Czech Republic, August 28-September 1, 2005 (M. Potáček and J. Dostál, Eds), PO-70. Masaryk University, Brno 2005;
45. b) Jampílek J., Opletalová V., Grafnetterová T., Dohnal J.: Proceedings of the 9th International Electronic Conference on Synthetic Organic Chemistry, November 1-30, 2005 (J. A. Seijas and M. P. V. Tato, Eds) [CD-ROM edition]. MDPI, Basel 2005; http://www.usc.es/congresos/ ecsoc/9/GOS/a001/index.htm.
46. a) Jampílek J., Opletalová V., Pour M., Kuneš J., Silva L., Buchta V., Richardson D. R., Kalinowski D. S., Al-Hallak L., Honcová D.: Proceedings of Joint Meeting 2006 of the Czech Pharmaceutical Society, German Pharmaceutical Society and Austrian Pharmaceutical Society, Marburg, Germany, October 4-7, 2006, C-76. German Pharmaceutical Society, Frankfurt/Main 2006;
47. b) Jampílek J., Opletalová V., Dohnal J.: Proceedings of the 10th International Electronic Conference on Synthetic Organic Chemistry, November 1-30, 2006 (J. A. Seijas and M. P. V. Tato, Eds) [CD-ROM edition]. MDPI, Basel 2006; http://www.usc.es/congresos/ecsoc/10/ECSOC10.htm.
48. Doležel J., Opletalová V., Silva L., Buchta V.: Proceedings of the 34th Conference "Synthesis and Analysis of Drugs", Brno, Czech Republic, September 12-14, 2005, p. 54. Veterinary and Pharmaceutical University, Brno 2005.
49. Lipinski C. A., Lombardo F., Dominy B. W., Feeney P. J.: Adv. Drug Delivery Rev. 1997, 23, 3.
50. a) Avdeef A.: Curr. Top. Med. Chem. 2001, 1, 277;
51. b) Pliska V. in: Lipophilicity in Drug Action and Toxicology (V. Pliska, B. Testa and H. van der Waterbeemd, Eds), pp. 1-6. Wiley-VCH, Weinheim 1996;
52. c) Musiol R., Jampilek J., Buchta V., Silva L., Niedbala H., Podeszwa B., Palka A., Majerz-Maniecka K., Oleksyn B., Polanski J.: Bioorg. Med. Chem. 2006, 14, 3592;
53. d) Vinšová J., Čermáková K., Tomečková A., Čečková M., Jampílek J., Čermák P., Kuneš J., Doležal M., Štaud F.: Bioorg. Med. Chem. 2006, 14, 5850.
54. Gocan S., Cimpan G., Comer J.: Adv. Chromatogr. 2006, 44, 79.
55. a) Valko K.: J. Chromatogr., A 2004, 1037, 299;
56. b) Hartmann T., Schmitt J.: Drug Discovery Today Technol. 2004, 1, 431.
57. a) Nie S. Q., Kwan C. Y., Epand R. M.: Eur. J. Pharmacol., Mol. Pharmacol. Sect. 1993, 244, 15;
58. b) Nie S. Q., Majarais I., Kwan C. Y., Epand R. M.: Eur. J. Pharmacol., Mol. Pharmacol. Sect. 1994, 266, 11.
59. Houminer Y., Southwick E. W., Williams D. L.: J. Org. Chem. 1989, 54, 640.
60. a) Hanai T. Hubert J.: J. Liq. Chromatogr. 1985, 8, 2463;
61. b) Baranowska I., Kubik T.: J. Planar Chromatogr. 1991, 4, 467;
62. c) Baranowska I., Swierczek S.: J. Planar Chromatogr. 1995, 8, 357;
63. d) Piraprez G., Hérent M. F., Collin S.: Flavour Fragr. J. 1998, 13, 400;
64. e) Yamagami C., Takao N., Fujita T.: Prog. Clin. Biol. Res. 1989, 291, 83;
65. f) Yamagami C., Ogura T., Takao N.: J. Chromatogr. 1990, 514, 123;
66. g) Yamagami C., Takao N., Fujita T.: Quant. Struct.-Act. Relat. 1990, 9, 313;
67. h) Yamagami C., Takao N.: Chem. Pharm. Bull. 1991, 39, 1217;
68. i) Yamagami C., Takao N.: Chem. Pharm. Bull. 1991, 39, 2924;
69. j) Yamagami C., Takao N.: Chem. Express 1991, 6, 113;
70. k) Yamagami C., Takao N.: Chem. Pharm. Bull. 1992, 40, 925;
71. l) Garni-Yilinkou R., Kaliszan R.: Pol. J. Pharmacol. Pharm. 1992, 44, 515;
72. m) Yamagami C., Takao N., Fujita T.: J. Pharm. Sci. 1993, 82, 155;
73. n) Yamagami C., Yokota M., Takao N.: Chem. Pharm. Bull. 1994, 42, 907;
74. o) Yamagami C., Iwasaki K., Ishikawa A.: Chem. Pharm. Bull. 1997, 45, 1953;
75. p) Yamagami C., Araki K., Ohnishi K., Hanasato K., Inaba H., Aono M., Ohta A.: J. Pharm. Sci. 1999, 88, 1299;
76. q) Yamagami C., Kawase K., Fujita T.: Quant. Struct.-Act. Relat. 1999, 18, 26;
77. r) Yamagami C., Fujita T.: J. Pharm. Sci. 2000, 89, 1505;
78. s) Yamagami C., Haraguchi M.: Chem. Pharm. Bull. 2000, 48, 1973;
79. t) Yamagami C., Kawase K., Iwaki K.: Chem. Pharm. Bull. 2002, 50, 1578;
80. u) Tanaka H., Liu X., Kawabata D., Chuman H., Yamagami C.: Chem. Pharm. Bull. 2005, 53, 374.
81. a) Opletalová V., Hartl J., Kastner P., Podešt'ová D.: Proceedings of the 27th Conference "Synthesis and Analysis of Drugs", Bratislava, Slovak Republic, September 10-12, 1998; in: Farm. Obzor 1998, 67, 193;
82. b) Opletalová V., Palát K., Jr., Kastner P.: Proceedings of the 32nd Conference "Synthesis and Analysis of Drugs", Velké Karlovice, Czech Republic, September 16-19, 2003, p. 76. Czech Pharmaceutical Society, Hradec Králové 2003.
83. a) Hansch C., Leo A., Unger S. H., Kim K. H., Nikaitani D., Lien E. J.: J. Med. Chem. 1973, 16, 1207;
84. b) Norrington F. E., Hyde R. M., Williams S. G., Wootton R.: J. Med. Chem. 1975, 18, 604.
85. SciFinder Scholar™ [database on-line]. American Chemical Society 2006; http://www.cas.org/Scifinder/Scholar/index.html.